论文部分内容阅读
目的研究利凡诺用于中期妊娠疤痕子宫引产的疗效及安全性。方法选取有剖宫产史的中期妊娠疤痕子宫引产孕妇61例为观察组;另选取同期无剖宫产史221例中期妊娠利凡诺引产者做为对照组。用利凡诺100mg羊膜腔内注射,用药后对疗效指标进行观察。结果两组患者用药后规律宫缩发动时间、胎儿娩出时间、产后2h出血量、引产成功率、软产道裂伤率、胎盘残留率差异均无统计学意义。结论利凡诺用于疤痕子宫中期妊娠引产安全、有效。
Objective To study the efficacy and safety of rivanol in inducing uterine abortion in mid-term pregnancy. Methods Sixty-one pregnant women with mid-term pregnancy with uterine scar induced by cesarean section were selected as the observation group. 221 pregnant women with no history of cesarean section during the same period were enrolled as the control group. With rivanol 100mg amniotic cavity injection, the efficacy of indicators after the observation. Results After treatment, the regular contractile time, the time of delivery of fetus, the amount of bleeding 2h postpartum, the success rate of induction of labor, the rate of soft birth canal laceration and the residual rate of placenta were not significantly different between the two groups. Conclusions Rivanol is safe and effective for induction of labor during mid-term pregnancy with scar.